Intracerebral propagation of Alzheimer's disease: Strengthening evidence of a herpes simplex virus etiology

Alzheimer's and Dementia

Volumn 9, Issue 2, 2013, Pages 169-175

  Ball, Melvyn J ^a   Lukiw, Walter J ^b   Kammerman, Eli M ^c   Hill, James M ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Louisiana State University Health Sciences Center ^*

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICRORNA; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; DRUG MECHANISM; ENDOCYTOSIS; ENDOSOME; ENTORHINAL CORTEX; EXOSOME; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOSURVEILLANCE; LATENT PERIOD; NERVE CELL; NEUROFIBRILLARY TANGLE; PHOSPHORYLATION; PRIORITY JOURNAL; RISK FACTOR; SYNAPSE; TRIGEMINAL NERVE;

EID: 84875365096     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.07.005     Document Type: Note

References (79)

1. L. Liu, V. Drouet, J.W. Wu, M.P. Witter, S.A. Small, and C. Clelland Trans-synaptic spread of tau pathology in vivo PLoS One 7 2012 e31302
2. Kolata G. Faulty protein is like a virus in Alzheimer's. New York Times, February 1, 2012.
3. B. Ehlers, J. Kuchler, N. Asmun, G. Dural, S. Voigt, and J. Schmidt-Chanasit Identification of novel rodent herpesviruses, including the first gammaherpesviruses of Mus musculus J Virol 81 2007 8091 8100
4. M.J. Ball Limbic predilection in Alzheimer dementia: Is reactivated herpesvirus involved? Can J Neurol Sci 9 1982 303 306
5. M.J. Ball The essential lesion of Alzheimer disease: A surprise in retrospect J Alzheimer Dis 9 suppl 2006 29 33
6. A.M. Deatly, A.T. Haase, P.H. Fewster, E. Lewis, and M.J. Ball Human herpes virus infections and Alzheimer's disease Neuropathol Appl Neurobiol 16 1990 213 223
7. J.G. Stevens, L. Haarr, D.D. Porter, M.L. Cook, and E.K. Wagner Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans J Infect Dis 15 1988 117 123
8. K.D. Croen, J.M. Ostrove, L. Dragovic, and S.E. Straus Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture J Infect Dis 163 1991 23 28
9. P.H. Fewster, S. Griffin-Brooks, J. MacGregor, E. Ojalvo-Rose, and M.J. Ball A topographical pathway by which histopathological lesions disseminate through the brain of patients with Alzheimer's disease Dementia Geriatr Cogn Disord 2 1991 121 132
10. H. Braak, and K. Del Tredici Alzheimer's pathogenesis: Is there neuron-to-neuron propagation? Acta Neuropathol 121 2011 589 595
11. H. Braak, D.R. Thal, E. Grebremedhin, and K. Del Tredici Stages of pathologic process in Alzheimer disease: Age categories from 1 to 100 years J Neuropathol Exp Neurol 70 2011 960 969
12. M.J. Ball, K. Nuttall, and K.G. Warren Neuronal and lymphocytic populations in human trigeminal ganglia: Implications for ageing and for latent virus Neuropathol Appl Neurobiol 8 1982 177 187
13. L. Letenneur, K. Peres, I. Garrigue, P. Barberger-Gateau, C. Helmer, and J.M. Orgogozo Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: A population-based cohort study PLoS One 3 2008 e3637
14. S. McQuaid, I.V. Allen, J. McMahon, and J. Kirk Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: A combined in situ hybridization and immunocytochemical investigation Neuropathol Appl Neurobiol 20 1994 103 110
15. M.J. Ball Unexplained sudden amnesia, postencephalitic Parkinson disease, subacute sclerosing panencephalitis, and Alzheimer disease: Does viral synergy produce neurofibrillary tangles? Arch Neurol 60 2003 641 642
16. A.S. Armien, S. Hu, M.R. Little, N. Robinson, J.R. Lokensgard, W.C. Low, and M.C.J. Cheeran Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis Brain Pathol 20 2010 738 750
17. E. Mylonas, A. Hascher, P. Bernado, M. Blackledge, E. Mandelkow, and D.I. Svergun Domain conformation of tau protein studied by solution small-angle X-ray scattering Biochemistry 47 2008 10345 10353
18. G. Esposito, C. Scuderi, J. Lu, C. Savani, D. De Filippis, and T. Iuvone S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells J Cell Mol Med 12 2008 914 927
19. J.N. Marcus, and J. Schachter Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease J Neurogenet 25 2011 127 133
20. M.A. Wozniak, A.L. Frost, C.M. Preston, and R.F. Itzhaki Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1 PLoS One 6 2011
21. G. Alvarez, J. Aldudo, M. Alonso, S. Santana, and F. Valdivieso Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells J Neurosci Res 90 2012 1020 1029
22. M.A. Wozniak, A.L. Frost, and R.F. Itzhaki Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1 J Alzheimer Dis 16 2009 341 350
23. E. Masliah, D.S. Iimoto, M. Mallory, T. Albright, L. Hansen, and T. Saitoh Casein kinase II alteration precedes tau accumulation in tangle formation Am J Pathol 140 1992 263 268
24. M. Raftery, R. Campbell, E.N. Glaros, K.A. Rye, G.M. Halliday, and W. Jessup Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro Biochemistry 44 2005 7346 7353
25. J. Avila, L. Ulloa, J. Gonzalez, F. Moreno, and J. Diaz-Nido Phosphorylation of microtubule-associated proteins by protein kinase CK2 in neuritogenesis Cell Mol Biol Res 40 1994 573 579
26. G. Elliott, D. O'Reilly, and P. O'Hare Identification of phosphorylation sites within the herpes simplex virus tegument protein VP22 J Virol 73 1999 6203 6206
27. B.J. Geiss, G.L. Cano, J.E. Tavis, and L.A. Morrison Herpes simplex virus 2 VP22 phosphorylation induced by cellular and viral kinases does not influence intracellular localization Virology 330 2004 74 81
28. E.E. Morrison, Y.F. Wang, and D.M. Meredith Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument J Virol 72 1998 7108 7114
29. G. Elliott, D. O'Reilly, and P. O'Hare Phosphorylation of the herpes simplex virus type I tegument protein VP22 Virology 226 1996 140 145
30. R. Asai, T. Ohno, A. Kato, and Y. Kawaguchi Identification of proteins directly phosphorylated by UL13 protein kinase from herpes simplex virus 1 Microbes Infect 9 2007 1434 1438
31. Y. Kawaguchi, and K. Kato Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2 Rev Med Virol 13 2003 331 340
32. U. Chuluunbaatar, R. Roller, M.E. Feldman, S. Brown, K.M. Shokat, and I. Mohr Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication Genes Dev 24 2010 2627 2639
33. G.A. Jamieson, N.J. Maitland, G.K. Wilcock, J. Craske, and R.F. Itzhaki Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains J Med Virol 33 1991 224 227
34. R.F. Itzhaki, and W.R. Lin Herpes simplex virus type I in brain and the type 4 allele of the apolipoprotein E gene are a combined risk factor for Alzheimer's disease Biochem Soc Trans 26 1998 273 277
35. M.A. Wozniak, A.P. Mee, and R.F. Itzhaki Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques J Pathol 217 2009 131 138
36. G.A. Jamieson, N.J. Maitland, K. Wilcock, C.M. Yates, and R.F. Itzhaki Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type J Pathol 167 1992 365 368
37. G.A. Jamieson, N.J. Maitland, J. Craske, G.K. Wilcock, and R.F. Itzhaki Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer's disease brain using polymerase chain reaction Biochem Soc Trans 19 1991 122S
38. W.R. Lin, J. Graham, S.M. MacGowan, G.K. Wilcock, and R. Itzhaki Alzheimer's disease, herpes virus in brain, apolipoprotein E4 and herpes labialis Alzheimer Rep 1 1998 173 178
39. W.R. Lin, M.A. Wozniak, R.J. Cooper, G.K. Wilcock, and R.F. Itzhaki Herpesviruses in brain and Alzheimer's disease J Pathol 197 2002 395 402
40. R.F. Itzhaki, N.J. Maitland, G.K. Wilcock, C.M. Yates, and G.A. Jamieson Detection by polymerase chain reaction of herpes simplex virus type 1 (HSV1) DNA in brain of aged normals and Alzheimer's disease patients B. Corain, K. Iqbal, M. Nicolini, B. Winblad, H. Wisniewski, P. Zatta, Alzheimer's disease: Advances in clinical and basic research 1993 John Wiley & Sons Chichester, UK 97 102
41. M.A. Wozniak, S.J. Shipley, M. Combrinck, G.K. Wilcock, and R.F. Itzhaki Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients J Med Virol 75 2005 300 306
42. V.J. Sanders, S.L. Felisan, A.E. Waddell, A.J. Conrad, P. Schmid, and B.E. Swartz Presence of herpes simplex DNA in surgical tissue from human epileptic seizure foci detected by polymerase chain reaction: Preliminary study Arch Neurol 54 1997 954 960
43. U. Beffert, P. Bertrand, D. Champagne, S. Gauthier, and J. Poirier HSV-1 in brain and risk of Alzheimer's disease Lancet 351 1998 1330 1331
44. P. Bertrand, D. Guillaume, K. Hellauer, D. Dea, J. Lindsay, and S. Kogan Distribution of herpes simplex virus type 1 DNA in selected areas of normal and Alzheimer's disease brains: A PCR study Neurodegeneration 2 1993 201 208
45. W. Liedtke, B. Opalka, C.W. Zimmermann, and E. Lignitz Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue J Neurol Sci 116 1993 6 11
46. J.A. Nicoll, S. Love, and E. Kinrade Distribution of herpes simplex virus DNA in the brains of human long-term survivors of encephalitis Neurosci Lett 157 1993 215 218
47. N. Hemling, M. Roytta, J. Rinne, P. Pollanen, E. Broberg, and V. Tapio Herpesviruses in brains in Alzheimer's and Parkinson's diseases Ann Neurol 54 2003 267 271
48. V.J. Sanders, S. Felisan, A. Waddell, and A.A. Tourtellotte Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction J Neurovirol 2 1996 249 258
49. J.M. Hill, P.S. Bhattacharjee, and D.M. Neumann Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease Exp Eye Res 84 2007 801 811
50. R.F. Itzhaki, and W.R. Lin Herpes simplex virus type I in brain and the type 4 allele of the apolipoprotein E gene are a combined risk factor for Alzheimer's disease Biochem Soc Trans 26 1998 273 277
51. ε4 in Alzheimer's disease J Neurovirol 7 2001 570 571
52. J.M. Hill, M. Ball, D. Neumann, A. Azcuy, P. Bhattacharjee, and S. Bouhanik The high prevalence of HSV-1 DNA in human trigeminal ganglia is not a function of age or gender J Virol 82 2008 8230 8234
53. R.F. Itzhaki, W.R. Lin, D. Shang, G.K. Wilcock, B. Faragher, and G.A. Jamieson Herpes simplex virus type 1 in brain and risk of Alzheimer's disease Lancet 349 1997 241 244
54. R.F. Itzhaki, C.B. Dobson, and M.A. Wozniak Herpes simplex virus type 1 and Alzheimer's disease Ann Neurol 55 2004 299 300
55. M.A. Wozniak, A.P. Mee, and R.F. Itzhaki Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques J Pathol 217 2009 131 138
56. H.S. Toma, A.T. Murina, R.G. Areaux Jr., D.M. Neumann, P.S. Bhattacharjee, and T.P. Foster Ocular HSV-1 latency, reactivation and recurrent disease Sem Ophthalmol 23 2008 249 273
57. L.J. Al-Dujaili, P.P. Clerkin, C. Clement, H.E. McFerrin, P.S. Bhattacharjee, and E.D. Varnell Ocular herpes simplex virus: How are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol 6 2011 877 907
58. J.M. Hill, M.A. Rayfield, and Y. Haruta Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits Curr Eye Res 6 1987 91 97
59. J.M. Hill, B.M. Gebhardt, A.M. Azcuy, K.E. Matthews, W.J. Lukiw, and I. Steiner Can a herpes simplex virus type 1 neuroinvasive score be correlated to other risk factors in Alzheimer's disease? Med Hypotheses 64 2005 320 327
60. R.F. Itzhaki, W.R. Lin, G.K. Wilcock, and B. Faragher HSV-1 and risk of Alzheimer's disease Lancet 352 1998 238
61. R.F. Itzhaki, and M.A. Wozniak Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? Alzheimer Dement 6 2010 83 84
62. R.B. Pyles The association of herpes simplex virus and Alzheimer's disease: A potential synthesis of genetic and environmental factors Herpes 8 2001 64 68
63. J.M. Hill, I. Steiner, K.E. Matthews, S.G. Trahan, T.P. Foster, and M.J. Ball Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of herpes simplex virus type 1 Med Hypotheses 64 2004 53 58
64. M.D.M. Haag, A. Hofman, P.J. Koudstaal, B.H.C. Stricker, and M.M.B. Breteler Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study J Neurol Neurosurg Psychiatry 80 2009 13 17
65. D.L. Sparks, R.J. Kryscio, M.N. Sabbagh, D.J. Connor, L.M. Sparks, and C. Liebsack Reduced risk of incident AD with elective statin use in a clinical trial cohort Curr Alzheimer Res 5 2008 416 421
66. P.C. Reid, Y. Urano, T. Kodama, and T. Hamakubo Alzheimer's disease: Cholesterol, membrane rafts, isoprenoids and statins J Cell Mol Med 11 2007 383 392
67. X.K. Tong, C. Lecrux, and E. Hamel Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits J Neurosci 32 2012 4705 4715
68. X.K. Tong, N. Nicolakakis, A. Kocharyan, and E. Hamel Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease J Neurosci 25 2005 11165 11174
69. S. Hoyer, and P. Riederer Alzheimer disease - no target for statin treatment. A mini review Neurochem Res 32 2007 695 706
70. B. Wolozin, J. Manger, R. Bryant, J. Cordy, R.C. Green, and A. McKee Re-assessing the relationship between cholesterol, statins and Alzheimer's disease Acta Neurol Scand Suppl 185 2006 63 70
71. B. Wolozin, W. Kellman, P. Ruosseau, G.G. Celesia, and G. Siegel Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors Arch Neurol 57 2000 1439 1443
72. B. Wolozin, S.W. Wang, N.C. Li, A. Lee, T.A. Lee, and L.E. Kazis Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease BMC Med 5 2007 20
73. E.M. Kammerman, D.M. Neumann, M.J. Ball, W. Lukiw, and J.M. Hill Senile plaques in Alzheimer's diseased brains: Possible association of beta-amyloid with herpes simplex virus type 1 (HSV-1) L-particles Med Hypotheses 66 2006 294 299
74. D.G. Meckes Jr., and N. Raab-Traub Microvesicles and viral infection J Virol 85 2011 12844 12854
75. W.J. Lukiw, J.G. Cui, L.Y. Yuan, P.S. Bhattacharjee, M. Corkern, and C. Clement Acyclovir or A[beta]42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells NeuroReport 21 2010 922 927
76. Y.Y. Li, J.G. Cui, J.M. Hill, S. Bhattacharjee, Y. Zhao, and W.J. Lukiw Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models Neurosci Lett 487 2011 94 98
77. D.M. Pegtel, M.D.B. van de Garde, and J.M. Middeldorp Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion Biochim Biophys Acta 1809 2011 715 721
78. B.J. Marshall, and J.R. Warren Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1 1984 1311 1315
79. S.J. Soscia, J.E. Kirby, K.J. Washicosky, S.M. Tucker, M. Ingelsson, and B. Hyman The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide PLoS One 5 2010 e9505